Zobrazeno 1 - 10
of 212
pro vyhledávání: '"Vernerey, J."'
Autor:
Grenier JMP; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France.; UMR 7268, Aix-Marseille Université, EFS, CNRS, GENGLOBE, Marseille, France., Testut C; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Bal M; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France.; Département de la Recherche Clinique et de l'Innovation, Institut Paoli-Calmettes, Marseille, France., Bardin F; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., De Grandis M; Aix-Marseille University, CNRS, EFS, ADES, Biologie des Groupes Sanguins, Marseille, France.; UMR 7268, Aix-Marseille Université, EFS, CNRS, GENGLOBE, Marseille, France., Gelsi-Boyer V; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Vernerey J; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Delahaye M; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Granjeaud S; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Zemmour C; Département de la Recherche Clinique et de l'Innovation, Institut Paoli-Calmettes, Marseille, France., Spinella JF; Laboratory of Molecular Genetics of Stem Cells, Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada., Chavakis T; Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Mancini SJC; UMR 1236, University of Rennes, INSERM, Etablissement Français du Sang Bretagne, Rennes, France., Boher JM; Département de la Recherche Clinique et de l'Innovation, Institut Paoli-Calmettes, Marseille, France., Hébert J; Division of Hematology-Oncology, Department of Medicine, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal, QC, Canada., Sauvageau G; Laboratory of Molecular Genetics of Stem Cells, Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada., Vey N; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Schwaller J; Department of Biomedicine, University Children's Hospital, University of Basel, Basel, Switzerland., Hospital MA; Département d'Hématologie, Institut Paoli-Calmettes, Marseille, France., Fauriat C; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France., Aurrand-Lions M; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France.
Publikováno v:
Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4662-4678.
Autor:
Legrand S; Centre de recherche en cancérologie de Marseille, CNRS UMR 7258, INSERM, Aix Marseille Université, Institut Paoli Calmettes, Marseille 13009, France., Saifudeen A; Centre de recherche en cancérologie de Marseille, CNRS UMR 7258, INSERM, Aix Marseille Université, Institut Paoli Calmettes, Marseille 13009, France., Bordelet H; Institut Pasteur, CNRS UMR 3525, Université Paris Cité, Unité Régulation Spatiale des Génomes, Paris 75015, France., Vernerey J; Centre de recherche en cancérologie de Marseille, CNRS UMR 7258, INSERM, Aix Marseille Université, Institut Paoli Calmettes, Marseille 13009, France., Guille A; Centre de recherche en cancérologie de Marseille, CNRS UMR 7258, INSERM, Aix Marseille Université, Institut Paoli Calmettes, Marseille 13009, France., Bignaud A; Institut Pasteur, CNRS UMR 3525, Université Paris Cité, Unité Régulation Spatiale des Génomes, Paris 75015, France., Thierry A; Institut Pasteur, CNRS UMR 3525, Université Paris Cité, Unité Régulation Spatiale des Génomes, Paris 75015, France., Acquaviva L; Centre de recherche en cancérologie de Marseille, CNRS UMR 7258, INSERM, Aix Marseille Université, Institut Paoli Calmettes, Marseille 13009, France., Gaudin M; Centre de recherche en cancérologie de Marseille, CNRS UMR 7258, INSERM, Aix Marseille Université, Institut Paoli Calmettes, Marseille 13009, France., Sanchez A; Institut Curie, Paris Sciences and Lettres University, Sorbonne Université, CNRS UMR 3244, Dynamics of Genetic Information, Paris 75005, France., Johnson D; Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN1 9RH, United Kingdom., Friedrich A; Université de Strasbourg, CNRS, Génétique moléculaire, génomique, microbiologie UMR 7156, Strasbourg 67000, France., Schacherer J; Université de Strasbourg, CNRS, Génétique moléculaire, génomique, microbiologie UMR 7156, Strasbourg 67000, France., Neale MJ; Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN1 9RH, United Kingdom., Borde V; Institut Curie, Paris Sciences and Lettres University, Sorbonne Université, CNRS UMR 3244, Dynamics of Genetic Information, Paris 75005, France., Koszul R; Institut Pasteur, CNRS UMR 3525, Université Paris Cité, Unité Régulation Spatiale des Génomes, Paris 75015, France., Llorente B; Centre de recherche en cancérologie de Marseille, CNRS UMR 7258, INSERM, Aix Marseille Université, Institut Paoli Calmettes, Marseille 13009, France.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Mar 19; Vol. 121 (12), pp. e2312820121. Date of Electronic Publication: 2024 Mar 13.
Autor:
Poplineau, M., Platet, N., Mazuel, A., Hérault, L., Koide, S., Kuribayashi, W., Carbuccia, N., N’guyen, L., Vernerey, J., Oshima, M., Birnbaum, D., Iwama, A., Duprez, Estelle
Cancer relapse is caused by a subset of malignant cells that are resistant to treatment. To characterize resistant cells and their vulnerabilities, we studied the retinoic acid (RA)-resistant PLZF-RARA acute promyelocytic leukemia (APL) using single-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::532d2770e6ac1ebd83ea602da23efd1d
https://hal.science/hal-03622501
https://hal.science/hal-03622501
Autor:
Poplineau M; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Equipe Labellisée Ligue Nationale Contre le Cancer., Platet N; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Mazuel A; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Hérault L; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer.; MABioS, I2M, Aix Marseille University,CNRS UMR7373, Marseille, France., N'Guyen L; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Koide S; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Nakajima-Takagi Y; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Kuribayashi W; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Carbuccia N; Predictive Oncology Laboratory, CRCM, Aix Marseille University, CNRS UMR7258, INSERM 1068, Institut Paoli-Calmettes, Marseille, France., Haboub L; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer., Vernerey J; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France., Oshima M; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Birnbaum D; Predictive Oncology Laboratory, CRCM, Aix Marseille University, CNRS UMR7258, INSERM 1068, Institut Paoli-Calmettes, Marseille, France., Iwama A; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Duprez E; Epigenetic Control of Normal and Malignant Hematopoiesis, CRCM, Aix Marseille University, CNRS UMR7258, INSERM U1068, Institut Paoli-Calmettes, Marseille, France.; Equipe Labellisée Ligue Nationale Contre le Cancer.
Publikováno v:
Blood [Blood] 2022 Dec 01; Vol. 140 (22), pp. 2358-2370.
Autor:
Bernard PL; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Delconte R; Immunology Program, Sloan-Kettering Institute, New York City, New York, USA., Pastor S; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Laletin V; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Costa Da Silva C; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Goubard A; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Josselin E; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Castellano R; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Krug A; INSERM, Unité 1111, Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique, Unité Mixte de Recherche (UMR) 5308, CIRI-International Center for Infectiology Research, Nice, France., Vernerey J; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Devillier R; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Olive D; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Verhoeyen E; INSERM, Unité 1111, Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique, Unité Mixte de Recherche (UMR) 5308, CIRI-International Center for Infectiology Research, Nice, France., Vivier E; Innate Pharma Research Labs, Innate Pharma; Centre d'Immunologie de Marseille-Luminy, CIML; Service d'Immunologie, Marseille Immunopole, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Aix Marseille Université, Inserm, CNRS, Marseille, France., Huntington ND; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia., Nunes J; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France., Guittard G; Immunity and Cancer Team, Onco-Hemato Immuno-Onco Department, OHIO, Institut Paoli-Calmettes, Inserm, CNRS, Cancer Research Centre, CRCM, Marseille, France geoffrey.guittard@inserm.fr.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 May; Vol. 10 (5).
Autor:
Rigo R; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Chelbi R; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France.; Inovarion, Paris, France., Agopian J; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Letard S; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Griffon A; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Ghamlouch H; INSERM, Mixed Research Unit (UMR) 1170, Institut Gustave Roussy, Facility of Medicine, Paris-Sud University, Paris-Saclay University, Equipe Labélisée Ligue Nationale Contre le Cancer, Villejuif, France., Vernerey J; CRCM, Institut Paoli-Calmettes, Inserm, CNRS, Aix Marseille University, Marseille, France., Ladopoulos V; Department of Haematology, Cambridge Institute for Medical Research, and.; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Voisset E; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., De Sepulveda P; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Guittard G; CRCM, Institut Paoli-Calmettes, Inserm, CNRS, Aix Marseille University, Marseille, France., Nunès JA; CRCM, Institut Paoli-Calmettes, Inserm, CNRS, Aix Marseille University, Marseille, France., Bidaut G; CRCM, Institut Paoli-Calmettes, Inserm, CNRS, Aix Marseille University, Marseille, France., Göttgens B; Department of Haematology, Cambridge Institute for Medical Research, and.; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Weber M; CNRS, University of Strasbourg, UMR7242 Biotechnology and Cell Signaling, Illkirch, France., Bernard OA; INSERM, Mixed Research Unit (UMR) 1170, Institut Gustave Roussy, Facility of Medicine, Paris-Sud University, Paris-Saclay University, Equipe Labélisée Ligue Nationale Contre le Cancer, Villejuif, France., Dubreuil P; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Soucie E; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France.
Publikováno v:
JCI insight [JCI Insight] 2022 Apr 08; Vol. 7 (7). Date of Electronic Publication: 2022 Apr 08.
Autor:
Cherif C; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France.; Laboratory of Biochemistry and Molecular Biology, Science University of Tunis, 2092, El Manar, Tunis, Tunisia., Nguyen DT; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Paris C; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Le TK; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Sefiane T; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Carbuccia N; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Finetti P; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Chaffanet M; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Kaoutari AE; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Vernerey J; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Fazli L; The Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., Gleave M; The Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., Manai M; Laboratory of Biochemistry and Molecular Biology, Science University of Tunis, 2092, El Manar, Tunis, Tunisia., Barthélémy P; ARNA Laboratory, INSERM U1212, CNRS UMR 5320, University of Bordeaux, F-33076 Bordeaux, France., Birnbaum D; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Bertucci F; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France., Taïeb D; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France.; Biophysics and Nuclear Medicine Department, La Timone University Hospital, European Center for Research in Medical Imaging, Aix-Marseille University, F-13005 Marseille, France., Rocchi P; Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR 1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille University, 27 Bd. Leï Roure, F-13009 Marseille, France. palma.rocchi@inserm.fr.
Publikováno v:
Oncogene [Oncogene] 2022 Jan; Vol. 41 (1), pp. 125-137. Date of Electronic Publication: 2021 Oct 28.
Autor:
Dhiman, Sandhya1 (AUTHOR) dhimans@karmanos.org, Dhillon, Vikram1,2 (AUTHOR) vdhillon@med.wayne.edu, Balasubramanian, Suresh Kumar1 (AUTHOR) balasubs@karmanos.org
Publikováno v:
Cancers. Nov2024, Vol. 16 Issue 22, p3743. 18p.
Autor:
Sabater, Agustina1,2,3 (AUTHOR) asabater@qb.fcen.uba.ar, Sanchis, Pablo1,2,3 (AUTHOR), Seniuk, Rocio1,2 (AUTHOR), Pascual, Gaston1,2 (AUTHOR), Anselmino, Nicolas4 (AUTHOR), Alonso, Daniel F.5 (AUTHOR), Cayol, Federico6 (AUTHOR), Vazquez, Elba1,2 (AUTHOR), Marti, Marcelo1,2 (AUTHOR), Cotignola, Javier1,2 (AUTHOR), Toro, Ayelen1,2 (AUTHOR), Labanca, Estefania4 (AUTHOR), Bizzotto, Juan1,2,3 (AUTHOR) jbizzotto@qb.fcen.uba.ar, Gueron, Geraldine1,2 (AUTHOR) jbizzotto@qb.fcen.uba.ar
Publikováno v:
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11356. 18p.
Autor:
Shi, Yinghong1,2 (AUTHOR), Hao, Donglin1 (AUTHOR) haodonglin9@sina.com, Qian, Hui1,2 (AUTHOR) lstmmmlst@163.com, Tao, Zhimin1,2,3 (AUTHOR) jsutao@ujs.edu.cn
Publikováno v:
Experimental Hematology & Oncology. 10/16/2024, Vol. 13 Issue 1, p1-26. 26p.